Identification Generic Name (1S)-menthyl hexyl phosphonate group DrugBank Accession Number DB08201 Background Not Available Type Small Molecule Groups Experimental Structure 
 
 
 3D Download  MOL SDF 3D-SDF PDB SMILES InChI 
 
 
  Similar Structures Structure for (1S)-menthyl hexyl phosphonate group (DB08201) ×  Close Weight Average: 304.4052  Monoisotopic: 304.216731434  Chemical Formula C 16 H 33 O 3 P Synonyms Not Available Pharmacology Indication Not Available Reduce drug development failure rates Build, train, & validate machine-learning models with evidence-based and structured datasets. See how     Build, train, & validate predictive machine-learning models with structured datasets. See how Contraindications & Blackbox Warnings Avoid life-threatening adverse drug events Improve clinical decision support with information on  contraindications & blackbox warnings, population restrictions, harmful risks, & more. Learn more     Avoid life-threatening adverse drug events & improve clinical decision support. Learn more Pharmacodynamics Not Available Mechanism of action Target Actions Organism U Cholinesterase Not Available Humans Absorption Not Available Volume of distribution Not Available Protein binding Not Available Metabolism Not Available Route of elimination Not Available Half-life Not Available Clearance Not Available Adverse Effects Improve decision support & research outcomes With structured adverse effects data, including:  blackbox warnings, adverse reactions, warning & precautions, & incidence rates. Learn more     Improve decision support & research outcomes with our structured adverse effects data. Learn more Toxicity Not Available Pathways Not Available Pharmacogenomic Effects/ADRs  
 
 
 Not Available Interactions Drug Interactions  
 
 
 This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.  Not Available Food Interactions Not Available Categories Drug Categories Not Available Classification Not classified Affected organisms Not Available Chemical Identifiers UNII Not Available CAS number Not Available InChI Key WAVIZOVSJOXCKT-XHSDSOJGSA-N InChI InChI=1S/C16H33O3P/c1-5-6-7-8-11-20(17,18)19-16-12-14(4)9-10-15(16)13(2)3/h13-16H,5-12H2,1-4H3,(H,17,18)/t14-,15+,16-/m0/s1 IUPAC Name hexyl({[(1S,2R,5S)-5-methyl-2-(propan-2-yl)cyclohexyl]oxy})phosphinic acid SMILES CCCCCCP(O)(=O)O[C@H]1C[C@@H](C)CC[C@@H]1C(C)C References General References Not Available External Links PubChem Compound 446981 PubChem Substance 99444672 ChemSpider 394198 ZINC ZINC000005973164 PDBe Ligand MPC PDB Entries 1lps Clinical Trials Clinical Trials  
 
 
 Phase Status Purpose Conditions Count Pharmacoeconomics Manufacturers Not Available Packagers Not Available Dosage Forms Not Available Prices Not Available Patents Not Available Properties State Solid Experimental Properties Not Available Predicted Properties Property Value Source Water Solubility 0.0384 mg/mL ALOGPS logP 4.34 ALOGPS logP 4.58 Chemaxon logS -3.9 ALOGPS pKa (Strongest Acidic) 1.93 Chemaxon Physiological Charge -1 Chemaxon Hydrogen Acceptor Count 2 Chemaxon Hydrogen Donor Count 1 Chemaxon Polar Surface Area 46.53 Å 2 Chemaxon Rotatable Bond Count 8 Chemaxon Refractivity 84.04 m 3 ·mol -1 Chemaxon Polarizability 35.77 Å 3 Chemaxon Number of Rings 1 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter Yes Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon Predicted ADMET Features Property Value Probability Human Intestinal Absorption + 0.9841 Blood Brain Barrier + 0.9329 Caco-2 permeable + 0.5468 P-glycoprotein substrate Non-substrate 0.5429 P-glycoprotein inhibitor I Non-inhibitor 0.5578 P-glycoprotein inhibitor II Non-inhibitor 0.9095 Renal organic cation transporter Non-inhibitor 0.9001 CYP450 2C9 substrate Non-substrate 0.8084 CYP450 2D6 substrate Non-substrate 0.7953 CYP450 3A4 substrate Substrate 0.6334 CYP450 1A2 substrate Non-inhibitor 0.8461 CYP450 2C9 inhibitor Non-inhibitor 0.7973 CYP450 2D6 inhibitor Non-inhibitor 0.8921 CYP450 2C19 inhibitor Non-inhibitor 0.8028 CYP450 3A4 inhibitor Non-inhibitor 0.6856 CYP450 inhibitory promiscuity Low CYP Inhibitory Promiscuity 0.9095 Ames test Non AMES toxic 0.6676 Carcinogenicity Non-carcinogens 0.6701 Biodegradation Not ready biodegradable 0.9493 Rat acute toxicity 1.9734 LD50, mol/kg  Not applicable hERG inhibition (predictor I) Weak inhibitor 0.6445 hERG inhibition (predictor II) Non-inhibitor 0.6372    ADMET data is predicted using  admetSAR , a free tool for evaluating chemical ADMET properties. ( 23092397 )  Spectra Mass Spec (NIST) Not Available Spectra Not Available Targets Build, predict & validate machine-learning models Use our structured and evidence-based datasets to  unlock newinsights and accelerate drug research. Learn more     Use our structured and evidence-based datasets to unlock new insights and accelerate drug research. Learn more 
 
 
  Details 1.  Cholinesterase Kind Protein Organism Humans Pharmacological action Unknown General Function Identical protein binding Specific Function Esterase with broad substrate specificity. Contributes to the inactivation of the neurotransmitter acetylcholine. Can degrade neurotoxic organophosphate esters. Gene Name BCHE Uniprot ID P06276 Uniprot Name Cholinesterase Molecular Weight 68417.575 Da References Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [ Article ]  × Identify potential medication risks Easily compare up to 40 drugs with our drug interaction checker. Get severity rating, description, and management advice.  Learn more      Drug created at September 15, 2010 21:29 / Updated at June 12, 2020 16:52 